ASCO Guidelines
Un pódcast de American Society of Clinical Oncology (ASCO)
180 Episodo
-
Endocrine Treatment and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Guideline Update
Publicado: 29/7/2021 -
Chemotherapy and Targeted Therapy for Patients with Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative Guidelin
Publicado: 29/7/2021 -
Telehealth in Oncology: Standards and Practice Recommendations
Publicado: 28/7/2021 -
Salivary Gland Hypofunction and/or Xerostomia Induced by Non-Surgical Cancer Therapies: ISOO/MASCC/ASCO Guideline
Publicado: 20/7/2021 -
Management of the Axilla in Early-Stage Breast Cancer: OH (CCO) and ASCO Guideline
Publicado: 19/7/2021 -
Oncology Medical Home: ASCO and COA Standards
Publicado: 13/7/2021 -
Assessment of Adult Women with Ovarian Masses and Treatment of Epithelial Ovarian Cancer Resource Stratified Guideline
Publicado: 29/6/2021 -
Appropriate Systemic Therapy Dosing for Obese Adult Patients with Cancer Guideline Update
Publicado: 3/5/2021 -
Management of Salivary Gland Malignancy Guideline
Publicado: 26/4/2021 -
Management of Dyspnea in Advanced Cancer Guideline
Publicado: 22/2/2021 -
Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Guideline Update
Publicado: 16/2/2021 -
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer Guideline
Publicado: 28/1/2021 -
Radiation Therapy for Small Cell Lung Cancer Guideline Endorsement
Publicado: 27/1/2021 -
Initial Management of Non-Castrate Advanced, Recurrent, or Metastatic Prostate Cancer Guideline Update
Publicado: 26/1/2021 -
PREVIEW: ASCO in Action CEO & CMO Interview
Publicado: 19/1/2021 -
Chemotherapy in Combination with Radiotherapy for Definitive-intent Treatment of Stage II to IVA Nasopharyngeal Carcinoma: CSCO-ASCO Guideline
Publicado: 6/1/2021 -
Systemic Therapy for Advanced Hepatocellular Carcinoma Guideline
Publicado: 16/11/2020 -
Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer Guideline Update
Publicado: 20/10/2020 -
Treatment of Metastatic Carcinoma and Myeloma of the Femur: Joint MSTS/ASTRO/ASCO Guideline
Publicado: 1/10/2020 -
PARP Inhibitors in the Management of Ovarian Cancer Guideline
Publicado: 13/8/2020
Explore pivotal recommendations from the latest evidence-based clinical practice guidance with ASCO Guidelines. Join us to discover essential insights and navigate the ever-evolving landscape of cancer research and treatment.
